NewslettersCell Therapy NewsHuman Immunology NewsMesenchymal Cell NewsUmbilical & Placental Cell News FDA to Require Diversity Plan for Clinical Trials By lbeveridge - February 21, 2023 0 The FDA will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants. [Nature News] Full Article